Compare LAKE & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LAKE | IXHL |
|---|---|---|
| Founded | 1982 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.2M | 97.6M |
| IPO Year | 2013 | 2024 |
| Metric | LAKE | IXHL |
|---|---|---|
| Price | $8.51 | $3.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.33 | N/A |
| AVG Volume (30 Days) | 88.0K | ★ 4.9M |
| Earning Date | 03-18-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.36% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $167,211,000.00 | $12,000.00 |
| Revenue This Year | $19.87 | N/A |
| Revenue Next Year | $8.32 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2554.14 | N/A |
| 52 Week Low | $7.77 | $0.11 |
| 52 Week High | $21.19 | $5.17 |
| Indicator | LAKE | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 30.27 | 82.81 |
| Support Level | $7.77 | $0.31 |
| Resistance Level | $9.67 | $5.17 |
| Average True Range (ATR) | 0.35 | 0.25 |
| MACD | -0.09 | 0.39 |
| Stochastic Oscillator | 4.24 | 73.70 |
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.